Needle cover with undercut

Information

  • Patent Grant
  • 12324905
  • Patent Number
    12,324,905
  • Date Filed
    Friday, April 24, 2020
    5 years ago
  • Date Issued
    Tuesday, June 10, 2025
    4 months ago
Abstract
A needle cover for protecting a needle mounted on a tip of a barrel of a medical injection device, may include an inner shield, and an outer shield surrounding at least partially the inner shield, and fixed to said inner shield, wherein the needle cover may include an outer shield including a body including a first open end, a second end, and a sidewall extending between the first end and the second end, the body defining a cavity to receive an inner shield therein, a first undercut defined adjacent the first open end of the body.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is the United States national phase of International Application No. PCT/EP2020/061485 filed Apr. 24, 2020, and claims priority to Europe Patent Application No. 19305540.7 filed Apr. 26, 2019, the entire disclosures of which are hereby incorporated by reference in their entirety.


BACKGROUND OF THE INVENTION
Field of the Invention

The present disclosure relates generally to medical injection devices for delivery of a fluid or liquid medicament. More particularly, the present disclosure relates to a needle cover adapted to be mounted on a tip of a medical injection device for covering a needle attached thereon. The disclosure also relates to a medical assembly including a medical injection device and a needle cover for enclosing the needle of the medical injection device.


Description of Related Art

Medical injection devices such as syringes are well known in the art. These devices typically include a container for containing a medical composition such as a liquid medicament. Said container usually includes an end piece in a form of a longitudinal tip defining a fluid path through which the medical solution is expelled. A needle may be attached to the tip in order to prick the patient's skin and to perform the injection of the medical composition.


In order to maintain sterility prior to use and to reduce the risk of incurring an accidental needle-stick, protection of the needle is important. Thus, a needle cover may be mounted on the tip of the barrel so as to enclose the needle. This renders the needle physically inaccessible by the persons around the device. The needle cover may include an inner shield, in a material with elastomeric properties, and may further include an outer shield, in rigid plastic, surrounding the inner shield. The inner needle shield ensures the sealing of the medical injection device. To that purpose, the inner needle shield includes a sealing portion that sealingly contacts the outer surface of the syringe's tip to provide a tight seal. The inner needle shield prevents any contamination of the medical composition from the outside environment, thereby assuring the container closure integrity. The inner needle shield further prevents any leakage of composition from the outlet of the needle to the external environment. To that purpose, the needle is preferably pricked in the inner needle shield.


Immediately prior to use, the user must remove the protective needle cover from the medical injection device. The force needed to remove a needle cover is measured by a physical parameter called “pull out force” (also referred to as “POF”). The pull out force necessary for removing the known needle covers from an injection device, such as a syringe, may be quite high and is due in particular to the pressure exerted onto the tip by the inner needle shield which results in friction between the inner needle shield and the tip.


As a consequence, a user having a reduced strength, for example weakened by a disease, may not be able to remove the needle shield and use the injection device for his treatment.


Moreover, healthcare professional who often use injection devices, such as nurses, have a high risk of injuring themselves, since they may not control the force they apply for pulling off the needle cover from the injection device, which may result in uncontrolled and dangerous movements. Lastly, the needle of the syringe may be bent during the removing of the needle shield because of this high required pull out force.


SUMMARY OF THE INVENTION

In view of the problems identified above, there is a current need for a needle cover that allows reducing the pull out force needed for removing said needle cover from a medical injection device, and that does not decrease the tight sealing of said needle cover to the tip of the medical injection device (while keeping intact the no leakage property of the needle cover).


In one example of the present disclosure, a needle cover for protecting a needle mounted on a tip of a barrel of a medical injection device, wherein the tip extends from a distal end of the barrel, may include an inner shield extending along a longitudinal axis, including an inner proximal connection element configured to sealingly contact the tip of the barrel, and an outer shield surrounding at least partially the inner shield, and fixed to said inner shield, wherein said outer shield of the needle cover may include a body including a first open end, a second end, and a sidewall extending between the first end and the second end, the body defining a cavity to receive an inner shield therein, and an undercut defined adjacent the first open end of the body.


In another example of the present disclosure, the outer shield of the needle cover further comprises a second undercut defined adjacent the first open end of the body, wherein a longitudinal length of the first undercut extending from the first open end towards the second end is less than a longitudinal length of the second undercut extending from the first open end towards the second end.


In another example of the present disclosure, a distance from the first open end of the outer shield to a proximal edge of the first undercut present on the body of the outer shield is greater than a distance from the first open end of the outer shield to a proximal edge of the second undercut present on the body of the outer shield. A first latching tab may extend from an inner surface of the body of the outer shield proximate the first undercut, and a second latching tab may extend from the inner surface of the body of the outer shield proximate the second undercut. The first latching tab may have a circumferential width that is greater than a circumferential width of the second latching tab. The first and second latching tabs may include a proximal angled surface. A difference between a distance from the first open end of the outer shield to a proximal edge of the first undercut and a distance from the first open end of the outer shield to a proximal edge of the second undercut may be at least 1 millimeter. The first and second undercuts may be diametrically opposed to one another. The first and second undercuts may be rectangular in shape.


Moreover, the body may define at least one U-shaped groove on an outer surface thereof. The U-shaped groove may include a distal wall and a proximal wall that extend radially from the body. A distance from the first open end of the outer shield to a distal edge of the first undercut may be equal to a distance from the first open end of the outer shield to a distal edge of the second undercut.


In another example of the present disclosure, a medical assembly, comprising: a medical injection device, comprising: a barrel defining a reservoir adapted to contain a medical composition; a tip extending from a distal face of the barrel, defining a fluid path extending through the tip and in fluid communication with the reservoir, a needle being in communication with the reservoir; and a needle cover adapted to cover the needle; characterized in that: the needle cover comprises: an inner shield extending along a longitudinal axis, comprising an inner proximal connection element configured to sealingly contact the tip of the barrel; and an outer shield covering at least a portion of the inner shield, the outer shield comprising: a body including a first open end, a second end, and a sidewall extending between the first end and the second end, the body defining a cavity to receive the inner shield therein; and a first undercut defined adjacent the first open end of the body.


Advantageously, the outer shield of the medical assembly further comprises a second undercut distinct from the first undercut and defined adjacent the first open end of the body, wherein a longitudinal length of the first undercut extending from the first open end of the outer shield towards the second end of the outer shield is less than a longitudinal length of the second undercut extending from the first open end of the outer shield towards the second end of the outer shield.


The following clauses also are directed to the present invention and disclosure:


Clause 1: A needle cover for protecting a needle mounted on a tip of a barrel of a medical injection device, wherein the tip extends from a distal end of the barrel, the needle cover comprising: an inner shield extending along a longitudinal axis, comprising an inner proximal connection element configured to sealingly contact the tip of the barrel, and an outer shield surrounding at least partially the inner shield, and fixed to said inner shield, wherein the outer shield comprises a body including a first open end, a second end, and a sidewall extending between the first end and the second end, the body defining a cavity to receive an inner shield therein; and a first undercut defined adjacent the first open end of the body.


Clause 2: The needle cover of Clause 1, wherein the body of the outer shield further comprises a second undercut defined adjacent the first open end of the body, wherein a longitudinal length of the first undercut extending from the first open end of the outer shield towards the second end is less than a longitudinal length of the second undercut extending from the first open end of the outer shield towards the second end.


Clause 3: The needle cover of Clause 2, wherein a distance from the first open end to a proximal edge of the first undercut is greater than a distance from the first open end to a proximal edge of the second undercut.


Clause 4: The needle cover of Clause 2, further comprising: a first latching tab that extends from an inner surface of the body proximate the first undercut; and a second latching tab that extends from the inner surface of the body proximate the second undercut.


Clause 5: The needle cover of Clause 4, wherein the first latching tab has a circumferential width that is greater than a circumferential width of the second latching tab.


Clause 6: The needle cover of Clause 4, wherein the first and second latching tabs comprise a proximal angled surface.


Clause 7: The needle cover of Clause 2, wherein a difference between a distance from the first open end to a proximal edge of the first undercut and a distance from the first open end to a proximal edge of the second undercut is at least 1 millimeter.


Clause 8: The needle cover of Clause 2, wherein the first and second undercuts are diametrically opposed to one another.


Clause 9: The needle cover of Clause 2, wherein the first and second undercuts are rectangular in shape.


Clause 10: The needle cover of Clause 1, wherein the body defines at least one U-shaped groove on an outer surface thereof.


Clause 11: The needle cover of Clause 10, wherein the U-shaped groove comprises a distal wall and a proximal wall that extend radially from the body.


Clause 12: The needle cover of Clause 2, wherein a distance from the first open end to a distal edge of the first undercut is equal to a distance from the first open end to a distal edge of the second undercut.


Clause 13: The needle cover of Clause 2, wherein the outer shield is fixed to the inner shield by a snap-fit connection, the inner proximal connection element of the inner shield is inserted in the first and second undercuts of the outer shield to form the snap-fit connection so that, when a pulling force is applied to the outer shield in a distal direction, the inner shield makes a first contact with end surface of the first undercut and then with an end surface of the second undercut, thereby flexing the inner shield in a radial direction to assist disengagement of the inner shield from the tip.


Clause 14: A medical assembly, comprising: a medical injection device, comprising: a barrel defining a reservoir adapted to contain a medical composition; a tip extending from a distal face of the barrel, defining a fluid path extending through the tip and in fluid communication with the reservoir, a needle in communication with the reservoir; and a needle cover of any of Clauses 1 to 12 and adapted to cover the needle; characterized in that: the needle cover comprises: an inner shield extending along a longitudinal axis, comprising an inner proximal connection element configured to sealingly contact the tip of the barrel; and an outer shield covering at least a portion of the inner shield, the outer shield comprising: a body including a first open end, a second end, and a sidewall extending between the first end and the second end, the body defining a cavity to receive the inner shield therein; and a first undercut defined adjacent the first open end of the body.


Clause 15: The medical assembly of Clause 14, wherein the barrel and the tip of the medical injection device are made of glass.





BRIEF DESCRIPTION OF THE DRAWINGS

The above-mentioned and other features and advantages of this disclosure, and the manner of attaining them, will become more apparent and the disclosure itself will be better understood by reference to the following descriptions of embodiments of the disclosure taken in conjunction with the accompanying drawings, wherein:



FIG. 1 is a perspective view of a medical injection device in accordance with an embodiment of the present invention;



FIG. 2 is a perspective view of the medical injection device of FIG. 1 with a needle cover in accordance with an embodiment of the present invention;



FIG. 3 is a front view of a needle cover in accordance with an embodiment of the present invention;



FIG. 4 is an isolated perspective view of the needle cover of FIG. 3;



FIG. 5 is a cross-sectional view of a proximal portion of the needle cover of FIG. 3;



FIG. 6 is an isolated perspective view of the proximal portion of the needle cover of FIG. 3; and



FIG. 7 is a perspective view of an inner shield in accordance with an embodiment of the present invention.





DESCRIPTION OF THE INVENTION

The following description is provided to enable those skilled in the art to make and use the described embodiments contemplated for carrying out the invention. Various modifications, equivalents, variations, and alternatives, however, will remain readily apparent to those skilled in the art. Any and all such modifications, variations, equivalents, and alternatives are intended to fall within the spirit and scope of the present invention.


For purposes of the description hereinafter, the terms “upper”, “lower”, “right”, “left”, “vertical”, “horizontal”, “top”, “bottom”, “lateral”, “longitudinal”, and derivatives thereof shall relate to the invention as it is oriented in the drawing figures. However, it is to be understood that the invention may assume various alternative variations, except where expressly specified to the contrary. It is also to be understood that the specific devices illustrated in the attached drawings, and described in the following specification, are simply exemplary embodiments of the invention. Hence, specific dimensions and other physical characteristics related to the embodiments disclosed herein are not to be considered as limiting.


In the following discussion, “distal” refers to a direction generally toward an end of a medical injection device adapted for contact with a patient's skin, and “proximal” refers to the opposite direction of distal, i.e., away from the end of a medical injection device. In other words, the “distal direction” is to be understood as meaning the direction of injection. The distal direction corresponds to the travel direction of the plunger during the injection, the medical composition contained initially in the barrel being expelled from the latter. The “proximal direction” is to be understood as meaning the opposite direction to said direction of injection. For purposes of this disclosure, the above-mentioned references are used in the description of the components of a medical injection device in accordance with the present disclosure.


Referring to FIG. 1, the medical injection device 10 includes a barrel 18 extending along a longitudinal axis X from a proximal face 36 to a distal face 34, defining a reservoir 20 for a medical composition such as a liquid medicament. The medical injection device 10 may also include a stopper (not shown), and a plunger rod 26 having a flange 68 and translationally movable inside the barrel 18 from a proximal position to a distal position for injecting the composition.


The medical injection device 10 further includes a distal tip 35 extending along the axis X from the distal face 34 of the barrel 18. The distal tip 35 is at least partially hollow so as to form a fluid path in fluidic communication with the barrel 18. A needle 14 may be attached to the distal tip 35 of the injection device 10 and is in fluid communication with the fluid path. It is noted herein that the distal face 34 of the barrel 18 is proximate the shoulder of the medical injection device.


The medical injection device 10 is preferably made of glass, and more preferably is a glass syringe. Such glass syringes are largely used in hospital environments and readily sterilizable. The medical injection device 10 is preferably a prefilled syringe. The medical injection device 10 is more preferably a syringe with a staked needle.


Referring to FIG. 2, the medical injection device further includes a needle cover 100. The needle cover 100 shields and covers the needle 14. The needle cover 100 may include an outer shield 101 and an inner shield 30 that covers the needle 14 and is covered by the outer shield 101.


Referring to FIG. 3, the outer shield 101 in accordance with an embodiment of the present invention is described in greater detail. The outer shield 101 is preferably made in a rigid material, such as rigid plastic. The outer shield 101 may be made of a medical grade plastic. The rigid material confers rigidity to the outer shield 101, which allows said outer shield 101 to better protect the needle cover 100 from shocks. The structural integrity of the needle cover 100 is thereby improved.


The outer shield 101 includes a body 102 having a proximal end 104 and a distal end 106. Said body 102 extends along a longitudinal axis Y. Said axis Y coincides with the axis X when the needle cover 100 is mounted on the tip 35 of the medical injection device 10.


In one example, the body 102 may be substantially cylindrical in shape. The body 102 may define an inner cavity 108 (see FIG. 6) that at least partially receives the inner shield 30 of the medical injection device 10. A collar 110 may be formed on the proximal end 104 of the outer shield 101. The collar 110 may have a larger diameter than the remaining portion of the body 102. In one example, a plurality of ribs and grooves 112, 114 may be defined on the body 102 of the outer shield 101. The ribs and grooves 112, 114 may be provided adjacent the distal end 106 of the outer shield 101. The ribs and grooves 112, 114 provide a gripping surface for a user to use when pulling the outer shield 101 away from the medical injection device 10.


In another example shown in FIGS. 3 and 4, a U-shaped groove 116 may be formed in a side surface of the body 102 to create another feature to assist a user in pulling the outer shield 101 away from the medical injection device 10. The U-shaped groove 116 includes a distal wall 118 and a proximal wall 119. The distal wall 118 of the U-shaped groove 116 allows a user to apply pressure against the outer shield 101 to create a greater pulling force to pull the outer shield 101 away from the medical injection device 10. The plurality of ribs and grooves 112, 114 may be provided along said U-shaped groove 116.


With reference to FIG. 5, the collar 110 of the body 102 of the outer shield 101 may define at least one undercut, preferably at least a pair of undercuts 120, 122. In one example, the undercuts 120, 122 are apertures that extend through the outer shield 101. The presence of the undercuts 120, 122 allows reducing the pull-out force required by a user to remove the outer shield 101 from the medical injection device 10, as discussed herein. The undercuts 120, 122 may also be referred to as “windows” that extend through the collar 110. Indeed, thanks to these windows, the user can visually ensure that the inner shield 30 is at least partially enclosed in the outer shield 101.


In one example, at least one of the undercuts 120, 122, preferably both undercuts 120, 122, may be substantially rectangular in shape. In one example, the undercuts 120, 122 may be diametrically opposed from one another on the collar 110. A longitudinal length A of the first undercut 120 may be less than a longitudinal length B of the second undercut 122. The longitudinal length A may be measured from a proximal surface 124 of the first undercut 120 to a distal surface 126 of the first undercut 120. The longitudinal length B may be measured from a proximal surface 128 of the second undercut 122 to a distal surface 130 of the second undercut 122. In another example, the distance from the proximal end 104 of the body 102 to the distal surface 126 of the first undercut 120 is substantially equal to a distance from the proximal end 104 of the body 102 to the distal surface 130 of the second undercut 122. When the longitudinal lengths A, B of the undercuts 120, 122 are different from one another, the undercuts 120, 122 are considered asymmetric from one another. In another example, a distance from the proximal end 104 of the body 102 to the proximal surface 124 of the first undercut 120 is greater than a distance from the proximal end 104 of the body 102 to the proximal surface 128 of the second undercut 122. In one example, the undercuts 120, 122 are extruded from the collar 110 of the body 102. It is also contemplated that any other manufacturing methods may be used to define the undercuts 120, 122 in the collar 110. Advantageously, the two undercuts 120, 122 are distinct from each other and define two different apertures in the collar 110.


With reference to FIG. 6, another feature of the outer shield 101 is described in detail. In particular, two latching tabs 132, 134 may inwardly extend from an inner surface of the collar 110 near the proximal end 104 of the body 102. The latching tabs 132, 134 may include an inclined surface 136 that is angled relative to the longitudinal axis Y of the outer shield 101, and a substantially planar surface 138 that extends parallel to a longitudinal axis Y of the outer shield 101. The latching tabs 132, 134 may assist in the insertion of the inner shield 30 into the inner cavity 108 of the outer shield 101. In one example, a circumferential width of one latching tab 134 is greater than a circumferential width of the other latching tab 132.


With reference to FIG. 7, the inner shield 30 that may be used in the invention is represented. Said inner shield 30 extends along a longitudinal axis Z. Said axis Z coincides with the axis Y when the inner shield 30 is at least partly enclosed in the outer shield 101. The inner shield 30 preferably has a cylindrical shape and a circular cross section. Advantageously, the inner shield 30 includes an inner proximal connection part 140 configured to sealingly engage the tip 35 of the injection device 10, as shown in FIG. 1. The inner proximal connection part 140 has preferably a larger diameter that the rest of the inner shield 30. Said inner proximal connection part 140 may be shaped as a circumferential flange. The inner proximal connection part 140 is thus easier to distinguish from the rest of the body and the fixation of the inner shield 30 to the outer shield 101 is improved as described in the following.


The inner shield 30 is preferably made in a material with elastomeric properties. In this way, the inner proximal connection part 140 may slightly deform when connecting the inner shield 30 to the injection device 10 so as to match the shape of the tip 35. Meanwhile, the needle tip, or distal part of the needle 14, may penetrate the inner shield 30. This further reduces the risk of leakage of the medical composition via the needle 14 to the external environment. The material with elastomeric properties is preferably a thermoplastic elastomer, an elastomer, or a rubber. Preferably, the material with elastomeric properties is sterilizable.


In one embodiment, the outer shield 101 surrounds at least partially the inner shield 30. The outer needle shield 101 is fixed to the inner needle shield 30. To this end, the inner proximal connection part 140 of the inner shield 30 is partially inserted in the two undercuts 120, 122, in a snap-fit connection. The inner proximal connection part 140 of the inner shield 30 abuts both the proximal surfaces 124, 128 and the distal surfaces 126, 130 of both the undercuts 120, 122, thereby preventing any translational movement of the inner shield 30 along the axis Y relative to the outer shield 101. Advantageously, the inner proximal connection part 140 also abuts the side surfaces of the undercuts 120, 122, thereby preventing any rotational movement of the inner shield 30 around the axis Y relative to the outer needle shield 101.


The inner shield 30 and the outer shield 101 may be fixed together by other fixing means than the snap-fit connection of the undercuts 120, 122, and the inner proximal connection part 140 or in addition to said snap-fit connection. When the needle cover 100 is mounted on the injection device 10, the inner shield 30 encloses at least a portion of the tip 35 of the barrel 18, and the proximal connection part 140 firmly contacts a proximal portion of the tip 35. The needle cover 100 is thus tightly and sealingly connected to the tip 35.


In order to mount the needle cover 100 on the syringe, the outer shield 101 is firstly placed over the inner shield 30, and then the entire needle cover 100 is mounted on the syringe. As previously described, when the inner shield 30 and the outer shield 101 are fixed together, the proximal connection part 140 of the inner shield 30 will be locked into the undercuts 120, 122 defined in the collar 110 of the outer shield 101. Once locked into the undercuts 120, 122, the proximal connection part 140 is prevented from moving in a distal direction due to the distal surfaces 126, 130 of the undercuts 120, 122 and is prevented from moving in a proximal direction due to the proximal surfaces 124, 128 of the undercuts 120, 122.


After the needle cover 100 has been positioned on the medical injection device 10, the needle cover 100 can be moved in a distal direction to remove it from the medical injection device 10. As a pulling force is applied to the outer shield 101 by a user, the outer shield 101 is moved in the distal direction along with the inner shield 30. As the outer shield 101 is moved in the distal direction, the proximal surface 124 of the first undercut 120 will begin to contact and abut the proximal connection part 140 of the inner shield 30. Once the proximal surface 124 of the undercut 120 contacts the proximal connection part 140, the proximal surface 124 begins to push the proximal connection part 140 in a distal direction. As the proximal connection part 140 is pushed in the distal direction, the proximal connection part 140 begins to flex such that a collar 142 of the inner shield 30 is pulled in a radial direction away from the medical injection device 10.


As the proximal connection part 140 is pulled away in the radial direction due to contact with the proximal surface 124 of the first undercut 120, the opposing side of the proximal connection part 140 is flexed towards the proximal surface 128 of the second undercut 122. Due to the engagement between the opposing side of the proximal connection part 140 and the proximal surface 128, the second undercut 122 begins to assist in pulling the inner shield 30 off of the syringe tip 35 of the medical injection device 10. Once the outer shield 101 has been pulled a sufficient distance, the inner shield 30 is pulled off of the syringe tip 35 of the medical injection device 10.


All of the components of the medical injection device 10 may be constructed of any known material, and are desirably constructed of medical-grade polymers.


While this disclosure has been described as having exemplary designs, the present disclosure can be further modified within the spirit and scope of this disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the disclosure using its general principles. Further, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which this disclosure pertains and which fall within the limits of the appended claims.


The application will be further described with the non-limited example below.


Example Measurement of the Pull Out Force


Measurement of the pull out force.


Needle covers including an inner shield and an outer shield of the prior art (which the outer shield does not include any undercut) or outer shield of the invention, both being previously mounted onto the tip of a glass syringe, are compared herein. The glass syringes are identical for both the needle covers of the prior art and the needle covers of the invention.


In these assays, 5 outer shields of the prior art and 5 outer shields of the invention provided with two undercuts as described in the invention are provided.


Measurements of the force needed to remove the needle cover from the syringe are carried out. The test is performed with a traction bench (500 mm/min). The method includes the steps of: placing the syringe on a holder, holding the needle cover with pneumatic jaws, and pulling the needle cover at a constant displacement rate to remove it. The force needed to pull the needle cover so as to remove it from the tip is recorded. The results are represented in the table here below.















Pull out force (N)
Mean value





















Prior art needle cover
16.30
17.31
18.30
17.99
17.49
17.48


Invention needle cover
9.82
11.76
13.82
14.14
12.93
12.49









The force recorded is the maximum value of the force needed to remove the needle cover recorded in function of time. Said force is the pull-out force, named “POF value”. As visible in Table 1, the mean value of the POF recorded for the needle cover of the prior art is 17.48 N and the mean value of the POF recorded for the needle cover of the invention is 12.49. These values of the pull out force clearly show that the needle cover of the invention leads to a strong decrease of the pull out force compared to the known needle covers. The pull out force reduction is about 29%.

Claims
  • 1. A needle cover for protecting a needle mounted on a tip of a barrel of a medical injection device, wherein the tip extends from a distal end of the barrel, the needle cover comprising: an inner shield extending along a longitudinal axis configured to sealingly contact the tip of the barrel, andan outer shield surrounding at least partially the inner shield, and fixed to said inner shield, the outer shield comprising: a body including a first open end, a second end, and a sidewall extending between the first open end and the second end, the body defining a cavity to receive the inner shield therein;a first undercut defined in the sidewall adjacent the first open end of the body; anda second undercut defined in the sidewall adjacent the first open end of the body,wherein a distance from the first open end to a proximal edge of the first undercut is greater than a distance from the first open end to a proximal edge of the second undercut,the inner shield comprises a proximal connection part received in the first undercut and the second undercut,wherein during a removal of the needle cover from the medical injection device, as the outer shield is moved in the distal direction under a pulling force, the proximal end of the first undercut is configured to first contact the proximal connection part and an opposing side of the proximal connection part is configured to be flexed towards the proximal end of the second undercut, andwherein engagement between the proximal connection part and the proximal end of the second undercut is configured to assist in disengagement of the inner shield from the tip.
  • 2. The needle cover of claim 1, wherein a longitudinal length of the first undercut extending from the first open end towards the second end is less than a longitudinal length of the second undercut extending from the first open end towards the second end.
  • 3. The needle cover of claim 1, further comprising: a first latching tab that extends from an inner surface of the body proximate the first undercut; anda second latching tab that extends from the inner surface of the body proximate the second undercut.
  • 4. The needle cover of claim 3, wherein the first latching tab has a circumferential width that is greater than a circumferential width of the second latching tab.
  • 5. The needle cover of claim 3, wherein the first and second latching tabs comprise a proximal angled surface.
  • 6. The needle cover of claim 1, wherein a difference between the distance from the first open end to the proximal edge of the first undercut and the distance from the first open end to the proximal edge of the second undercut is at least 1 millimeter.
  • 7. The needle cover of claim 1, wherein the first and second undercuts are rectangular in shape.
  • 8. The needle cover of claim 1, wherein the body defines at least one U-shaped groove on an outer surface thereof.
  • 9. The needle cover of claim 8, wherein the U-shaped groove comprises a distal wall and a proximal wall that extend radially from the body.
  • 10. The needle cover of claim 1, wherein a distance from the first open end to a distal surface of the first undercut is equal to a distance from the first open end to a distal surface of the second undercut.
  • 11. The needle cover of claim 1, wherein the outer shield is fixed to the inner shield by a snap-fit connection, and the proximal connection part of the inner shield is inserted in the first and second undercuts of the outer shield to form the snap-fit connection.
  • 12. A medical assembly, comprising: a medical injection device, comprising: a barrel defining a reservoir adapted to contain a medical composition;a tip extending from a distal face of the barrel, defining a fluid path extending through the tip and in fluid communication with the reservoir; anda needle in communication with the reservoir; andthe needle cover according to claim 1 adapted to cover the needle.
  • 13. The medical assembly according to claim 12, wherein the barrel and the tip of the medical injection device are made of glass.
Priority Claims (1)
Number Date Country Kind
19305540 Apr 2019 EP regional
PCT Information
Filing Document Filing Date Country Kind
PCT/EP2020/061485 4/24/2020 WO
Publishing Document Publishing Date Country Kind
WO2020/216918 10/29/2020 WO A
US Referenced Citations (178)
Number Name Date Kind
2864364 Mizzy Dec 1958 A
3931815 Takatsuki Jan 1976 A
4248246 Ikeda Feb 1981 A
4317446 Ambrosio et al. Mar 1982 A
4468223 Minagawa et al. Aug 1984 A
4551138 Shinohara Nov 1985 A
4573977 Crawford Mar 1986 A
4735311 Lowe et al. Apr 1988 A
4964866 Szwarc Oct 1990 A
4986818 Imbert et al. Jan 1991 A
5085647 Henderson et al. Feb 1992 A
5098400 Crouse et al. Mar 1992 A
5147325 Mitchell et al. Sep 1992 A
5217025 Okamura Jun 1993 A
5451213 Teicher et al. Sep 1995 A
5484413 Gevorgian Jan 1996 A
5505705 Galpin et al. Apr 1996 A
5709659 Bennwik et al. Jan 1998 A
5980495 Heinz et al. Nov 1999 A
6015396 Buttgen et al. Jan 2000 A
6355017 Buttgen et al. Mar 2002 B2
6485474 Heinz et al. Nov 2002 B1
6544233 Fukui et al. Apr 2003 B1
6551286 Claessens Apr 2003 B1
6695819 Kobayashi Feb 2004 B2
6719732 Courteix Apr 2004 B2
7094223 Brunel Aug 2006 B2
7331941 Vetter et al. Feb 2008 B2
7387617 Wittland et al. Jun 2008 B2
7559919 Pech et al. Jul 2009 B2
7641636 Moesli et al. Jan 2010 B2
7722572 Sprinkle et al. May 2010 B2
7771368 Nakamura et al. Aug 2010 B2
8057441 Tsubota Nov 2011 B2
8096977 Ayiyama et al. Jan 2012 B2
8123724 Gillespie, III Feb 2012 B2
8277421 Koyama et al. Oct 2012 B2
8372105 Nishiuchi et al. Feb 2013 B2
8425468 Weston Apr 2013 B2
8460212 Nakamura et al. Jun 2013 B2
8469985 Nishiuchi Jun 2013 B2
8512295 Evans et al. Aug 2013 B2
8657780 Palmer-Felgate Feb 2014 B2
8672894 Bonnet Mar 2014 B2
8734402 Sharp et al. May 2014 B2
8747357 Stamp et al. Jun 2014 B2
8771235 Chevallier et al. Jul 2014 B2
8858507 Nielsen et al. Oct 2014 B2
8858508 Lavi et al. Oct 2014 B2
8900197 Crow Dec 2014 B2
8913123 Miller Dec 2014 B2
8961460 Yokota et al. Feb 2015 B2
9084854 Evans et al. Jul 2015 B2
9132266 Hayakawa et al. Sep 2015 B2
9192729 Iwase et al. Nov 2015 B2
9248245 Ekman et al. Feb 2016 B2
9278179 Schoonmaker Mar 2016 B2
9295785 Ekman et al. Mar 2016 B2
9302053 Holmqvist Apr 2016 B2
9314574 Roberts et al. Apr 2016 B2
9333305 McLoughlin et al. May 2016 B2
9339600 Weston May 2016 B2
9339610 Julian et al. May 2016 B2
9352099 Roberts et al. May 2016 B2
9415176 Benson et al. Aug 2016 B1
9468724 Evans et al. Oct 2016 B2
9468726 Lundquist Oct 2016 B2
9545484 Bicknell et al. Jan 2017 B2
9545485 Takemoto Jan 2017 B2
9757526 Iwase et al. Sep 2017 B2
9808584 Takemoto Nov 2017 B2
9839752 Fournier et al. Dec 2017 B2
9861761 Gonzales et al. Jan 2018 B2
9867950 Takemoto Jan 2018 B2
9919107 Imai et al. Mar 2018 B2
9919109 Arinobe et al. Mar 2018 B2
9925327 Okihara et al. Mar 2018 B2
RE46789 Olson Apr 2018 E
9950124 Imai et al. Apr 2018 B2
9962497 Takemoto May 2018 B2
9962498 Horita et al. May 2018 B2
10369289 Cabiri et al. Aug 2019 B2
10537688 Wittland et al. Jan 2020 B2
10653848 Wittland et al. May 2020 B2
11040148 Swal et al. Jun 2021 B2
11305062 Fabien et al. Apr 2022 B2
20040186440 Jansen et al. Sep 2004 A1
20050215952 Brunel et al. Sep 2005 A1
20060212021 Yazaki et al. Sep 2006 A1
20070250016 Pech et al. Oct 2007 A1
20080183140 Paproski et al. Jul 2008 A1
20080215013 Felix-Faure Sep 2008 A1
20080269690 Felix-Faure Oct 2008 A1
20090118678 Kawashima May 2009 A1
20090124981 Evans May 2009 A1
20100145227 Wessel Jun 2010 A1
20110118568 Sei May 2011 A1
20110202035 Voellmicke et al. Aug 2011 A1
20120179109 Takemoto et al. Jul 2012 A1
20120191048 Eaton Jul 2012 A1
20120238961 Julian Sep 2012 A1
20120330243 Liversidge Dec 2012 A1
20130012886 Kawachi Jan 2013 A1
20130030365 Liversidge Jan 2013 A1
20130053788 Dugand et al. Feb 2013 A1
20130072882 Ogawa et al. Mar 2013 A1
20130123711 Schoonmaker et al. May 2013 A1
20130174518 Tachikawa et al. Jul 2013 A1
20130204197 Bicknell et al. Aug 2013 A1
20130261563 Zachek Oct 2013 A1
20130274677 Ekman et al. Oct 2013 A1
20130296801 Takemoto et al. Nov 2013 A1
20140025013 Dowds et al. Jan 2014 A1
20140107577 Boyd et al. Apr 2014 A1
20140221873 Hayakawa et al. Aug 2014 A1
20140236102 Matsumoto et al. Aug 2014 A1
20140249479 Pfrang Sep 2014 A1
20140343503 Holmqvist Nov 2014 A1
20150174329 Takemoto Jun 2015 A1
20150190566 Okihara Jul 2015 A1
20150196720 Okihara et al. Jul 2015 A1
20150217061 Sadowski et al. Aug 2015 A1
20150258283 Imai et al. Sep 2015 A1
20150297837 Schraga Oct 2015 A1
20150335830 Horita et al. Nov 2015 A1
20150352291 Fournier et al. Dec 2015 A1
20160001006 Takemoto et al. Jan 2016 A1
20160001013 Fournier et al. Jan 2016 A1
20160001015 Kucuk et al. Jan 2016 A1
20160008553 Fournier et al. Jan 2016 A1
20160015905 Fournier et al. Jan 2016 A1
20160106929 Fournier et al. Apr 2016 A1
20160175539 Riedel et al. Jun 2016 A1
20160206829 Protasiewicz et al. Jul 2016 A1
20160220766 Kawano et al. Aug 2016 A1
20160243305 Nakamura et al. Aug 2016 A1
20160243315 Perche et al. Aug 2016 A1
20160271338 Fournier et al. Sep 2016 A1
20160271848 Takemoto et al. Sep 2016 A1
20160287810 Keim et al. Oct 2016 A1
20160296713 Schader et al. Oct 2016 A1
20160310676 Darras et al. Oct 2016 A1
20160325051 Keim et al. Nov 2016 A1
20160331904 Huthmacher et al. Nov 2016 A1
20160331908 Bode Nov 2016 A1
20160354550 Ward et al. Dec 2016 A1
20160354551 Keim et al. Dec 2016 A1
20160354552 Keim et al. Dec 2016 A1
20160367756 Felts et al. Dec 2016 A1
20170014578 Bunch Jan 2017 A1
20170021103 Mosebach et al. Jan 2017 A1
20170080159 Wei Mar 2017 A1
20170143893 Hasumi et al. May 2017 A1
20170182259 Fukushi et al. Jun 2017 A1
20170189603 Okihara et al. Jul 2017 A1
20170197040 Funatsu et al. Jul 2017 A1
20170203052 Abe et al. Jul 2017 A1
20170224932 Fournier et al. Aug 2017 A1
20170274151 Allen Sep 2017 A1
20170326306 Grosser Nov 2017 A1
20170361030 Moore Dec 2017 A1
20180011417 Shimizu et al. Jan 2018 A1
20180015229 Iwase Jan 2018 A1
20180015230 Okihara Jan 2018 A1
20180028762 Maxfield Feb 2018 A1
20180064885 Yamazaki et al. Mar 2018 A1
20180085534 Gonzales et al. Mar 2018 A1
20180104421 Wittland et al. Apr 2018 A1
20180110934 Wittland et al. Apr 2018 A1
20180140783 Raday May 2018 A1
20180161511 Fraas et al. Jun 2018 A1
20180272075 Stefanov et al. Sep 2018 A1
20180304030 Julian et al. Oct 2018 A1
20180311442 Saussaye et al. Nov 2018 A1
20180353702 Jugl Dec 2018 A1
20190201634 Newton Jul 2019 A1
20200061302 Alexandersson Feb 2020 A1
20210220565 Frost Jul 2021 A1
Foreign Referenced Citations (64)
Number Date Country
105007969 Jan 2018 CN
105007970 May 2018 CN
10316127 Nov 2004 DE
102011014200 Feb 2014 DE
102011017275 Apr 2014 DE
102013112654 May 2015 DE
SP077339 Apr 2007 EC
0498737 Jul 1995 EP
2172238 Apr 2010 EP
2548596 Jan 2013 EP
3325054 Mar 2021 EP
2777787 Apr 2001 FR
3003469 Apr 2016 FR
1235347 Jun 1971 GB
249004 Jan 2021 IL
257906 Jan 2022 IL
S5519160 Feb 1980 JP
H01212563 Aug 1989 JP
200754194 Mar 2007 JP
6042816 Dec 2016 JP
1020180006383 Jan 2018 KR
8900830 Feb 1989 WO
8908468 Sep 1989 WO
2007082226 Jul 2007 WO
2008016710 Feb 2008 WO
2008041437 Apr 2008 WO
2009104765 Aug 2009 WO
2011068130 Jun 2011 WO
2011068131 Jun 2011 WO
2011122393 Oct 2011 WO
2011122395 Oct 2011 WO
2011125475 Oct 2011 WO
2011125561 Oct 2011 WO
2012082818 Jun 2012 WO
2012133267 Oct 2012 WO
2013046857 Apr 2013 WO
2013047149 Apr 2013 WO
2013145998 Oct 2013 WO
2013146000 Oct 2013 WO
2013146099 Oct 2013 WO
2013146215 Oct 2013 WO
2013172104 Nov 2013 WO
2013183464 Dec 2013 WO
2013190941 Dec 2013 WO
2014033873 Mar 2014 WO
2014049797 Apr 2014 WO
2014115241 Jul 2014 WO
2014162439 Oct 2014 WO
2014184932 Nov 2014 WO
2015001819 Jan 2015 WO
2015029628 Mar 2015 WO
2015049945 Apr 2015 WO
2015105511 Jul 2015 WO
2015110533 Jul 2015 WO
2015147018 Oct 2015 WO
2016202498 Dec 2016 WO
2016202670 Dec 2016 WO
2017051108 Mar 2017 WO
2017051113 Mar 2017 WO
2017062938 Apr 2017 WO
2017081421 May 2017 WO
2018011417 Jan 2018 WO
2018172853 Sep 2018 WO
2019074788 Apr 2019 WO
Related Publications (1)
Number Date Country
20220184322 A1 Jun 2022 US